NEW YORK (GenomeWeb News) – The UK's Medical Research Council has awarded £10.6 million ($17.1 million) to three new multi-partner projects that plan to develop genome-based personalized medicine approaches to treating rheumatoid arthritis, hepatitis, and Gaucher disease.

Funded under MRC's Translational Research Group, these grants will support three research consortia involving more than 50 partners from academia and industry, as well as non-profits and patients from around the UK, MRC said on Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.